Shareholders Equity: The sum of preferred and common equity items.
Milestone Pharmaceuticals Inc. (MIST) had Shareholders Equity of $20.50M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-11.92M |
|
-- |
|
-- |
|
$11.83M |
|
$-11.83M |
|
$-0.09M |
|
$-11.92M |
|
$-11.92M |
|
$-11.92M |
|
$-11.92M |
|
$-11.92M |
|
$-11.92M |
|
$-11.83M |
|
$-11.80M |
|
96.50M |
|
96.50M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$86.67M |
|
$0.14M |
|
$1.08M |
|
$87.75M |
|
$10.52M |
|
$56.21M |
|
$56.73M |
|
$67.25M |
|
$20.50M |
|
$20.50M |
|
|
Shareholders Equity |
$20.50M |
85.17M |
|
| Cash Flow Statement Financials | |
$-36.27M |
|
$8.54M |
|
$49.09M |
|
$25.31M |
|
$46.69M |
|
$21.37M |
|
$3.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.24 |
|
-- |
|
-- |
|
0.73 |
|
2.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-36.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.15% |
|
-58.15% |
|
-13.59% |
|
-15.54% |
|
$0.24 |
|
$-0.38 |
|
$-0.38 |
|